| Name | Title | Contact Details |
|---|
SciAn Services Inc. is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medgenics is a clinical-stage biopharmaceutical company developing an innovative and proprietary platform technology - a biological "Biopump" - which allows patients to produce, within their bodies and on a long-term basis, their own natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C.
Recipharm was established in Sweden in 1995 and has since grown to become a leading Contract Development and Manufacturing Organisation (CDMO). Headquartered in Stockholm, we employ nearly 5 000 people and the Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. For over 20 years we have focussed on supporting pharmaceutical companies in taking their products from early development through to commercial manufacturing. Throughout the entire product lifecycle, we are there for our clients. Time and time again, we have delivered innovative solutions.
Calling Hospice of Southern Maine doesn`t mean you`re giving up, it means you`re taking charge. At Hospice of Southern Maine, our mission is to provide compassion, care and comfort through the end of life for patients with a terminal illnesses and their families. We care for patients where they are, whether at home, in a long-term care and assisted living center, or at Gosnell Memorial Hospice House, our 18-bed facility in Scarborough.
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.